|
|
|
题名
|
作者
|
年代
|
出处
|
被引量
|
| 1 | The KL-VS se- quence variant of Klotho and cancer risk in BRCA1 and BRCA2 mutation carriers显示文摘 | Laitman Y Kuchenbaecker K B Rantala J | 2012 | Breast Cancer Res Treat2012，132，3： | 1 |
| 2 | HMG- coenzyme A reductase inhibition, type 2 diabetes, and bodyweight: evidence from genetic analysis and randomised trials 显示文摘 | Swerdlow DI Preiss D Kuchenbaecker KB | 2015 | Lancet2015，385，9965： | 1 |
| 3 | The interleukin-6 receptor as a target for prevention of coronary heart disease: a mendelian randomisation analysis 显示文摘 | SWERDLOW D I HOLMES M V KUCHENBAECKER K B | 2012 | Lancet2012，379，9822： | 1 |
| 4 | HMG- coenzyme A reductase inhibition, type 2 diabetes, and bodyweight : evidence from genetic analysis and randomised trials显示文摘 | Swerdlow DI Preiss D Kuchenbaecker KB | 2015 | Lancet2015，385，9965： | 1 |
| 5 | Ovar-ian cancer susceptibility alleles and risk of ovarian cancer in BRCA1 and BRCA2 mutation carriers显示文摘 | Ramus SJ Antoniou AC Kuchenbaecker KB | | 0，，04： | 1 |
| 6 | HMG-coen- zyme A reductase inhibition, type 2 diabetes, and bodyweight: evidence from genetic analysis and randomised trials 显示文摘 | Swerdlow DI David P Kuchenbaecker KB | 2015 | Lan- cet2015，385，14： | 1 |
| 7 | The interleukin-6 receptor as a target forprevention of coronary heart disease:a mendelianrandomisation analysis显示文摘 | Swerdlow DI Holmes MV Kuchenbaecker KB | 2012 | Lancet2012，379，： | 1 |
| 8 | HMG-coenzyme A reductase inhibition, type 2 diabetes, and bodyweight: evidence from genetic analysis and randomised trials 显示文摘 | Swerdlow D I Preiss D Kuchenbaecker K B | 2015 | Lancet2015，385，9965： | 1 |
| 9 | The KL-VS sequence variant of Klotho and cancer risk in BRCA1 and BRCA2mutation carriers显示文摘 | Laitman Y Kuchenbaecker KB Rantala J | 2012 | Breast Cancer Res Treat2012，132，3： | 1 |
| 10 | Identification of six new susceptibility loci for invasive epithelial ovarian cancer显示文摘 | Kuchenbaecker K B Ramus S J Tyrer J | 2015 | Nat Genet2015，47，2： | 1 |
| 11 | Identification of six new susceptibility loci for invasive epithelial ovarian cancer 显示文摘 | Kuchenbaecker K B Ramus S J Tyrer J | 2015 | Na- ture genetics2015，47，2： | 1 |
| 12 | HMGcoenzyme A reductase inhibition,type 2 diabetes,and bodyweight:evidence from genetic analysis and randomised trials显示文摘 | Swerdlow DI Preiss D Kuchenbaecker KB | 2015 | Lancet2015，385，9965： | 1 |
您所在的机构暂未开通此部分的功能，请联系管理员